2-{[(4,5,6,7-2H4)-1H-1,3-benzodiazole-2-sulfinyl]methyl}-3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-1-ium-1-olate

• ChemBase编号: 172216
• 分子式: C16H14F3N3O3S
• 平均质量: 385.3608696
• 单一同位素质量: 385.07079698
• SMILES: c1cccc2c1[nH]c(n2)S(=O)Cc1c(c(cc[n+]1[O-])OCC(F)(F)F)C
• Canonical SMILES: O=S(c1nc2c([nH]1)cccc2)Cc1[n+]([O-])ccc(c1C)OCC(F)(F)F
• InChI: InChI=1S/C16H14F3N3O3S/c1-10-13(22(23)7-6-14(10)25-9-16(17,18)19)8-26(24)15-20-11-4-2-3-5-12(11)21-15/h2-7H,8-9H2,1H3,(H,20,21)
• InChIKey: OBGHBYDDJGHGNS-UHFFFAOYSA-N

名称和登记号

名称

• IUPAC标准名: 2-{[(4,5,6,7-^2H₄)-1H-1,3-benzodiazole-2-sulfinyl]methyl}-3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-1-ium-1-olate
• IUPAC传统名: 2-{[(4,5,6,7-^2H₄)-1H-1,3-benzodiazole-2-sulfinyl]methyl}-3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-1-ium-1-olate
• 别名: 2-[[[3-Methyl-1-oxido-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole-d4; Lansoprazole-d4 N-Oxide

登记号

• PubChem SID: 164228126
• PubChem CID: 71749745

理论计算性质

• Acid pKa: 9.346268
• 质子受体: 4
• 质子供体: 1
• LogD (pH = 5.5): 1.8243474
• LogD (pH = 7.4): 1.8201501
• Log P: 1.8244361
• 摩尔折射率: 91.8317 cm^3
• 极化性: 34.70155 Å^3
• 极化表面积: 80.44 Å^2
• 可自由旋转的化学键: 6
• 里宾斯基五规则: true

详细说明

Toronto Research Chemicals - L175037

A labelled impurity of Lansoprazole (L175000) formed during the bulk synthesis of the drug.

参考文献

• Kubo, K., et al.: Chem. Pharm. Bull., 38, 2853 (1990)
• Barradell, L., et al.: Drugs, 44, 225 (1990)
• Aydogmus, Z., et al.: Acta Pharm. Sci., 48, 45 (1990)